BWL Investments

BWL Investments is a private Canadian venture capital and holding company founded in 2016 by Braeden Lichti. Headquartered in Vancouver, the firm specializes in identifying and developing high-value opportunities within the biotechnology, pharmaceutical, and medical aesthetics industries. BWL Investments is notably the founding investor and a major shareholder of PMGC Holdings (formerly Elevai Labs), a company focused on regenerative medicine and aesthetic applications. Through its strategic management of subsidiaries like NorthStrive Biosciences, the firm oversees a pipeline of novel therapeutic assets, including engineered probiotics designed for muscle preservation in obesity treatment. The company's business model involves restructuring and financing emerging life science entities to facilitate their growth into the public markets. BWL Investments continues to play a central role in the strategic direction and clinical advancement of its portfolio companies.